Search Results

Genicular Artery Embolization: Building Evidence and Practice

Experts discuss current evidence and lessons learned, patient candidacy, go-to embolics and devices, barriers to widespread use, predictions for future practice, and more.

With Mark W. Little, FRCR; Joaquim Maurício da Motta-Leal-Filho, MD, PhD; and Yuji Okuno, MD

Embolotherapy: New Milestones and Horizons

By Vivian L. Bishay, MD

Stenting in Long, Complex Lesions Is Superior to the “Old Standard”

By Mark W. Mewissen, MD

Restenosis and the New Health Care Economy

The cost of freedom from restenosis and repeat intervention.

By Mark W. Burket, MD

Editor's Challenge

A panel of interventional experts weighs in on how they would access and treat a series of challenging access case presentations.
With John H. Rundback, MD, FSVM, FAHA, FSIR; Mark W. Burket, MD; Bruce H. Gray, DO; Craig Walker, MD; and Michael Wholey, MD, MBA

Endograft Treatment in the SFA

Current SFA stent graft technology has overcome early shortcomings and carries the potential to become the standard of care in selected patients.

By Mark W. Mewissen, MD

SFA Disease: Deciding What to Leave Behind

Evaluating the value of drug delivery and the role of permanent implants in treating superficial femoral artery disease.

By Mark W. Burket, MD

Aggressive DVT Management Strategies and Techniques

Experts share their experiences with early intervention using pharmacomechanical thrombectomy and temporary filter placement, which have shown rapid symptom resolution and encouraging outcomes.

By Mark W. Mewissen, MD; Anthony C. Venbrux, MD; and Peter H. Lin, MD

Ask the Experts: Perfect Pairing: Which Stent Properties Are the Best Match for Drug-Coated Balloons?

Experts weigh in on properties of available stent technology and which combinations could be used to improve femoropopliteal disease outcomes.

With Stavros Spiliopoulos, MD, PhD, EBIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Mark W. Burket, MD; and Thomas Zeller, MD

Guidelines for the Use of Optional (Retrievable and Convertible) Vena Cava Filters

A summary of the SIR multidisciplinary consensus statement.

By John A. Kaufman, MD

For Whom the Bell Tolls

By Tara M. Mastracci, MD, FRCSC, and Gustavo S. Oderich, MD

Roundtable Discussion: ESRD in the Age of the COVID-19 Pandemic

Managing patient needs, coagulation concerns, telemedicine use, and a look at what we can learn from the pandemic.

With Dirk M. Hentschel, MD; Karen Woo, MD, MS, DFSVS, FACS; and Prabir Roy-Chaudhury, MD, PhD, FRCP (Edin)

What Is the Relevance of Time in Acute Stroke Treatment?

Evaluating the impact of time in the treatment of large vessel occlusion strokes, considering reperfusion therapies, neuroimaging, and stroke pathophysiology.

By Shashvat M. Desai, MD, and Ashutosh P. Jadhav, MD, PhD

MSK Embolization: From the Established to the Emerging

Emerging evidence supporting integration of embolization into contemporary care for musculoskeletal conditions.

By Yuji Okuno, MD, PhD

Roundtable Discussion: AV Use of Covered Stents: Dos and Don’ts

Experts share their tips on when, how, or if to deploy covered stents in the setting of arteriovenous grafts and/or fistulas.

With Ziv Haskal, MD, FSIR, FAHA, FACR, FCIRSE; Theodore F. Saad, MD; Haimanot (Monnie) Wasse, MD, MPH, FASN, FASDIN

Interventional Market Assessment

A summary of the 8th Morgan Stanley Interventional Cardiology Conference provides insight into the trends that will be affecting endovascular care for the next several years.

By The ENDOVASCULAR TODAY Staff